Soterius and Celegence are pleased to announce that as a part of Soterius’ Series A financing round, Celegence Holdings LLC has made a significant strategic investment in Soterius, Inc., a provider of outsourced services, collaboration technologies, and data assets in the drug safety and medical affairs space. The investment and partnership create synergies for both Celegence and Soterius, allowing each to leverage the knowledge and experience of their respective teams in ord
We are delighted to support MAIA Pharmaceuticals with their regulatory strategy and operations for filings in Europe for a very important project which should mark their entry into the European Market. Soterius is focused on consistently exceeding customer expectations by collaborating at all levels to deliver relevant, timely, and cost-effective solutions. Click here to see the full copy of the press release.